Company news
Ebos Group Limited (NZX:EBO) news
Every Ebos Group Limited press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
EBOS Group Sees Capex Declining From FY27; Targets Mid-Single-Digit EBITDA Growth Over Medium-Term
April 30, 2026
EBO: Portfolio shift to high-growth sectors and disciplined investment drive sustained EBITDA growth
April 29, 2026
EBOS Group Issues Update To FY26 Earnings Outlook
April 21, 2026
ASX 200 stocks hitting fresh 52-week highs and lows – Week 12
March 15, 2026
EBOS Group Limited H1 Income Advances
February 25, 2026
EBO: Revenue up 13% and EBITDA up 3.2%, with FY26 guidance reaffirmed and strong segment growth
February 24, 2026
ASX Insider Trades: Directors bought and sold these 7 stocks last week
November 16, 2025
ASX 200 stocks with the best performance: Return, momentum, risk-vs-reward – Week 46
November 13, 2025
ASX 200 stocks hitting fresh 52-week highs and lows – Week 45
November 2, 2025
EBO: Solid FY25 growth, board renewal, and strategic investments set the stage for future expansion
October 29, 2025
ASX 200 Insider Trades: Directors bought and sold these 7 stocks last week
October 14, 2025
Insider Trades: 10 ASX 200 directors bought and sold these stocks last week
September 29, 2025
8 ASX 200 stocks hit fresh 52-week lows last week (and they all have one thing in common)
September 23, 2025
ASX reporting season wrap: Solid earnings, dividend surprises and a domestic revival
September 1, 2025
EBO: 12% revenue and 7.5% EBITDA growth achieved, with 7% EBITDA uplift targeted for FY 2026
August 26, 2025
Insider Trades: 6 ASX 200 directors bought and sold these stocks last week
June 10, 2025
EBO: EBOS Group's profit fell 19% on lower revenue, but interim dividend and expansion continued
February 18, 2025
EBO: Strong FY24 growth, higher dividends, board renewal, and strategic acquisitions drive future expansion
October 23, 2024
EBO: Strong FY 2024 growth with robust outlook, despite Chemist Warehouse contract ending
August 20, 2024
These ASX stocks enjoyed the biggest broker upgrades this week
July 9, 2024
The advice that shaped the careers of some of Australia’s best investors
October 1, 2023
"There isn't an Aussie fund manager who's not buying this stock right now"
September 14, 2023
Morgan Stanley: Challenging healthcare outlook results in 2 surprise rating changes
September 6, 2023
Morgan Stanley’s top healthcare picks for ASX reporting season
July 10, 2023
The top performing ASX small and mid-caps over the last 12 months (and 6 you should watch)
July 6, 2023
Where Morgan Stanley stands on these 8 healthcare stocks post-reporting season
March 1, 2023